echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Real case: CAR-T

    Real case: CAR-T

    • Last Update: 2021-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    CAR-T immunotherapy, also known as chisellular T-cell immunotherapy, is a new type of precision targeted therapy for cancer treatment, which has achieved good results in clinical treatment in recent years through the optimization and improvement of scientists, and is a very promising immunotherapy method that can eliminate cancer cells accurately, quickly and efficiently.
    today, xu will use two real CAR-T cells reported recently at home and abroad to treat clinical cases of cancer, to show you how patients are recovering with the help of CAR-T immunotherapy.
    Part 01 disappears from lymphoma to cancer cells, CAR-T immunotherapy saves happy families "and this is our best Christmas present of the year, and hopefully more people will be able to take this new treatment in the future."
    " - On Christmas Eve 2018, a British woman, HelenSus, was told by doctors that an ultrasound had revealed a grapefruit-sized lump in her chest.
    time, Sys is pregnant with the old three, the old and the second are also young children, babies.
    was unwell during her pregnancy, but never thought it was lymphoma.
    Helen's family, Whous, was extremely weak and had not had a good Christmas that year.
    she started chemotherapy almost immediately and gave birth to her third child 10 weeks later.
    but routine cancer treatment didn't help, and last fall her cancer was transferred to the bone marrow, liver and lungs.
    told her to plan for the worst.
    2019, Helen found that routine treatment was not working well.
    , Sys began to prepare memory boxes for his three young children so that they could grow up knowing all the memories associated with their mother.
    fortunately, earlier this year, Ms Sioss was informed that she could receive a new type of T-cell immunotherapy, which has just been approved by NHS England.
    the process of CAR-T immunotherapy Source: BBC ResearchSios sees a thy thy thym.
    she said it was her last hope.
    six months after receiving the CAR-T cell infusion, and most recently, when doctors examined her, she was told that the cancer cells had completely disappeared from her body.
    the whole family were so excited to hear the news that they burst into tears.
    said it was their best Christmas present of the year.
    she was prepared for the worst, but immunocellular therapy saved her life.
    said she hopes more people will be able to receive the new treatment in the future.
    Part 02 suffering from tumors and lupus erythematosus, CAR-T immunotherapy made her successfully cured" did not expect the treatment to work so well, my life and normal people are no different, do not need to take any drugs, just according to the doctor's instructions to review regularly on it.
    " - Shenzhen Evening News, "The world's first case!" CAR-T treated a cure for tumors and lupus erythematosus more than 20 years ago, wang Fangfang suffered from systemic lupus erythematosus, and since then she has relied daily on hormones and other drugs to control her condition.
    once stopped the drug will lead to aggravation of the disease, long-term drug side effects lead to her a variety of complications, such as body fat, hair loss, osteoporosis, she has been looking forward to one day can no longer take medicine.
    even worse, in June last year, Wang Fangfang's right leg began to ache and her condition progressed so quickly that she was soon unable to walk and needed a wheelchair.
    she was pathologically diagnosed with large B-cell lymphoma at Yichang Local Hospital, a tumor located at the right knee joint, more than a dozen centimeters in diameter, and damaged the collarbone, left groin lymph nodes and bone marrow.
    At the time of her despair, Wang Fangfang came down to Shenzhen Hospital of Peking University at the recommendation of her relatives, and after multidisciplinary discussion and rigorous ethical review and medical evaluation by the hospital, Wang Fangfang joined the team to participate in the clinical trial of CAR-T cell immunotherapy and accepted the composite dual-target CAR-T (CD1) 9/BCMA) cell immunotherapy treatment, 9 months after treatment (June 2020) review, in addition to the original lymphoma completely cleared, her body for many years of stubborn lupus erythematosus antibodies are also turned negative, which means that her lupus erythematosus has been clinically cured.
    after 9 months of CAR-T cell therapy, Wang Fangfang made a full recovery.
    , Wang Fangfang has been out of medication for 9 months, re-created black hair, body, physical and mental condition is good, full of expectations for the future of life.
    Part 03 From immune cells to immunotherapy, advances in science have brightened immune cells with two real clinical cases that show us the enormous potential of CAR-T immunotherapy in disease treatment, and T-cells have been transformed into CAR-T immune cells that can accurately kill cancer cells.
    in humans, in addition to T-cells, there are other types of immune cells that help the body fight pathogen damage.
    they work together to protect human health.
    scientists continue to study, more and more immune cells are being used to help patients get rid of the disease, I believe that the future of immunocellular therapy will bring more patients the gospel.
    advances in science and technology have made cancer less scary.
    To be ordinary, in addition to relying on advances in technology to help us fight disease, we can also store our immune cells, and wait until the future is needed to help us strengthen our immunity and treat diseases in case we need them."
    reference reading: . . .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.